Loading, pretreatment, and interindividual variability issues with clopidogrel dosing

被引：36

作者：

Bates, ER

Lau, WC

Bleske, BE

机构：

[1] Univ Michigan, Sch Med, Div Cardiovasc Dis, Dept Internal Med, Ann Arbor, MI 48109 USA

[2] Univ Michigan, Sch Med, Dept Anesthesiol, Ann Arbor, MI 48109 USA

[3] Univ Michigan, Sch Pharm, Ann Arbor, MI 48109 USA

来源：

CIRCULATION | 2005年 / 111卷 / 20期

关键词：

editorials; platelets; inhibitors; drugs; pharmacology;

D O I：

10.1161/CIRCULATIONAHA.105.536276

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2557 / 2559

页数：3

共 27 条

[1] High clopidogrel loading dose during coronary stenting:: effects on drug response and interindividual variability [J].

Angiolillo, DJ ;

Fernández-Ortiz, A ;

Bernardo, E ;

Ramírez, C ;

Sabaté, M ;

Bañuelos, C ;

Hernández-Antolín, R ;

Escaned, J ;

Moreno, R ;

Alfonso, F ;

Macaya, C .

EUROPEAN HEART JOURNAL, 2004, 25 (21) :1903-1910

[2] Controversies in antiplatelet therapy for patients with cardiovascular disease [J].

Bates, ER ;

Lau, WC .

CIRCULATION, 2005, 111 (17) :E267-E271

[3]

Brandt JT, 2005, J AM COLL CARDIOL, V45, p87A

[4] Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment [J].

Chen, WH ;

Lee, PY ;

Ng, W ;

Tse, HF ;

Lau, CP .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (06) :1122-1126

[5] A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) [J].

Gent, M ;

Beaumont, D ;

Blanchard, J ;

Bousser, MG ;

Coffman, J ;

Easton, JD ;

Hampton, JR ;

Harker, LA ;

Janzon, L ;

Kusmierek, JJE ;

Panak, E ;

Roberts, RS ;

Shannon, JS ;

Sicurella, J ;

Tognoni, G ;

Topol, EJ ;

Verstraete, M ;

Warlow, C .

LANCET, 1996, 348 (9038) :1329-1339

[6] Antiplatlet effects of a 600 mg loading dose of clopidogrel are not attenuated in patients receiving atorvastatin or simvastatin for at least 4 weeks prior to cononary artery stenting [J].

Gorchakova, O ;

von Beckerath, N ;

Gawaz, M ;

Mocz, A ;

Joost, A ;

Schömig, A ;

Kastrati, A .

EUROPEAN HEART JOURNAL, 2004, 25 (21) :1898-1902

[7] Clopidogrel for coronary stenting - Response variability, drug resistance, and the effect of pretreatment platelet reactivity [J].

Gurbel, PA ;

Bliden, KP ;

Hiatt, BL ;

O'Connor, CM .

CIRCULATION, 2003, 107 (23) :2908-2913

[8] Clopidogrel loading with eptifibatide to arrest the reactivity of platelets - Results of the clopidogrel loading with eptifibatide to arrest the reactivity of platelets (CLEAR PLATELETS) study [J].

Gurbel, PA ;

Bliden, KP ;

Zaman, KA ;

Yoho, JA ;

Hayes, KM ;

Tantry, US .

CIRCULATION, 2005, 111 (09) :1153-1159

[9] Time dependence of platelet inhibition after a 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention [J].

Hochholzer, W ;

Trenk, D ;

Frundi, D ;

Blanke, P ;

Fischer, B ;

Andris, K ;

Bestehorn, HP ;

Büttner, HJ ;

Neumann, FJ .

CIRCULATION, 2005, 111 (20) :2560-2564

[10] Pharmacology of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins), including rosuvastatin and pitavastatin [J].

Igel, M ;

Sudhop, T ;

von Bergmann, K .

JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (08) :835-845

← 1 2 3 →